These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 23361577)
1. Swimming through the gut: implications of fluid transport on the microbiome. Colgan SP Dig Dis Sci; 2013 Mar; 58(3):602-3. PubMed ID: 23361577 [No Abstract] [Full Text] [Related]
3. Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon. Bassil AK; Borman RA; Jarvie EM; McArthur-Wilson RJ; Thangiah R; Sung EZ; Lee K; Sanger GJ Br J Pharmacol; 2008 May; 154(1):126-35. PubMed ID: 18332851 [TBL] [Abstract][Full Text] [Related]
4. Stimulation of mucosal secretion by lubiprostone (SPI-0211) in guinea pig small intestine and colon. Fei G; Wang YZ; Liu S; Hu HZ; Wang GD; Qu MH; Wang XY; Xia Y; Sun X; Bohn LM; Cooke HJ; Wood JD Am J Physiol Gastrointest Liver Physiol; 2009 Apr; 296(4):G823-32. PubMed ID: 19179625 [TBL] [Abstract][Full Text] [Related]
5. Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone. Moeser AJ; Nighot PK; Engelke KJ; Ueno R; Blikslager AT Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G647-56. PubMed ID: 17053162 [TBL] [Abstract][Full Text] [Related]
6. Effect of a chloride channel activator, lubiprostone, on colonic sensory and motor functions in healthy subjects. Sweetser S; Busciglio IA; Camilleri M; Bharucha AE; Szarka LA; Papathanasopoulos A; Burton DD; Eckert DJ; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G295-301. PubMed ID: 19033530 [TBL] [Abstract][Full Text] [Related]
7. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD. Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179 [TBL] [Abstract][Full Text] [Related]
8. Activation of intestinal Cl- secretion by lubiprostone requires the cystic fibrosis transmembrane conductance regulator. Bijvelds MJ; Bot AG; Escher JC; De Jonge HR Gastroenterology; 2009 Sep; 137(3):976-85. PubMed ID: 19454284 [TBL] [Abstract][Full Text] [Related]
10. Lubiprostone activates Cl- secretion via cAMP signaling and increases membrane CFTR in the human colon carcinoma cell line, T84. Ao M; Venkatasubramanian J; Boonkaewwan C; Ganesan N; Syed A; Benya RV; Rao MC Dig Dis Sci; 2011 Feb; 56(2):339-51. PubMed ID: 21140215 [TBL] [Abstract][Full Text] [Related]
11. May the truth be with you: lubiprostone as EP receptor agonist/ClC-2 internalizing "inhibitor". Akiba Y; Kaunitz JD Dig Dis Sci; 2012 Nov; 57(11):2740-2. PubMed ID: 23001408 [No Abstract] [Full Text] [Related]
12. Clinical pharmacology of lubiprostone, a chloride channel activator in defecation disorders. Ginzburg R; Ambizas EM Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1091-7. PubMed ID: 18680443 [TBL] [Abstract][Full Text] [Related]